To bring COVID-19 under control a vaccine needs to be available to every nation, rich and poor—and it needs to happen quickly. But pharmaceutical breakthroughs are usually the result a slow process involving competition, ...
Oct 1, 2020
0
3
Firefighters and emergency medical services workers are at high risk of exposure to COVID-19 while on the job and pose an additional risk of transmitting the virus to others. Although vaccines are a promising public health ...
Feb 10, 2021
0
1
During pregnancy, expectant parents spend countless hours sifting through online resources to make the "right" medical choices for their baby. In addition to decorating a nursery and playing baby shower games, pregnant women ...
Aug 15, 2018
1
0
Germany's CureVac said Tuesday it is no longer seeking European regulatory approval for its coronavirus vaccine, and will focus instead on a more promising second-generation jab.
Oct 12, 2021
0
3
As cold and flu season ramps up, health care experts are once again on high alert for the possibility of a tripledemic, or a surge brought on by the respiratory viruses that cause COVID-19, the flu and respiratory syncytial ...
Oct 12, 2023
0
10
Early clinical trials of a second Russian coronavirus vaccine have proved successful, its developer said Thursday after Russia boasted of approving the world's first vaccine.
Oct 1, 2020
0
1
Some people in the United States have expressed concern over getting one of the three currently available COVID-19 vaccines due to fear of an allergic reaction to the ingredients. Two new studies being presented at this year's ...
Nov 5, 2021
0
4
BioNTech and Pfizer said Monday they will ramp up their coronavirus vaccine deliveries to the European Union, pledging to send up to 75 million extra doses to the bloc in the spring.
Feb 1, 2021
0
2
Officials offered new promises Thursday that Haiti would soon receive its first vaccine as the country of more than 11 million people reels from a spike in coronavirus cases and COVID-19 deaths that have saturated hospitals.
Jun 25, 2021
0
0
Researchers from the Butantan Institute and collaborators are developing a more potent version of the BCG vaccine that protects against tuberculosis. While the conventional immunizer reduced infection by 90% in experiments ...
Jul 3, 2024
0
0
